Natco Pharma Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "NATCO received Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)".
Natco Pharma Limited Press Release Jul 18 2026
Filed with NSE · · 2 pages · English
Release
Earlier from NATCO Pharma
- Natco Pharma Limited Press Release Jul 14 2026
- Press Release Jun 03 2026
- India’s Natco Pharma to expand into Nigeria, demerge agrochemicals unit
- Press Release Mar 20 2026
- Press Release Mar 03 2026
Later from NATCO Pharma
- Natco Pharma Limited Press Release Aug 21 2026
- Natco Pharma Limited Press Release Aug 25 2026
- Natco Pharma Limited Press Release Sep 28 2026
- Natco Pharma Limited has informed the Exchange regarding a press release dated October 19, 2026, titled "NATCO announces launch of Carboplatin Injection (generic of Paraplatin®) in the U.S. market".
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma